The role of oxidant injury in the pathophysiology of human thalassemias.
D001457:Anion Exchange Protein 1, Erythrocyte / Q000378:metabolism; D017304:Annexin A5 / Q000378:metabolism; D017209:Apoptosis / Q000502:physiology; D001798:Blood Proteins / Q000378:metabolism; D001853:Bone Marrow / Q000473:pathology; D016022:Case-Control Studies; D053181:Caspase 8; D020169:Caspases / Q000378:metabolism; D003598:Cytoskeletal Proteins; D015672:Erythroid Precursor Cells / Q000378:metabolism*; D004920:Erythropoiesis / Q000502:physiology; D006461:Hemolysis / Q000502:physiology; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000209:etiology / Q000503:physiopathology; D008223:Lymphoma / Q000097:blood / Q000209:etiology / Q000503:physiopathology; D008564:Membrane Potentials; D008565:Membrane Proteins; D008928:Mitochondria; D016877:Oxidants; D018384:Oxidative Stress / Q000502:physiology*; D017086:beta-Thalassemia / Q000097:blood / Q000209:etiology* / Q000503:physiopathology*; D019014:fas Receptor / Q000378:metabolism
D001457:Anion Exchange Protein 1, Erythrocyte; D017304:Annexin A5; D001798:Blood Proteins; D003598:Cytoskeletal Proteins; D008565:Membrane Proteins; D016877:Oxidants; C044791:erythrocyte membrane band 4.2 protein; D019014:fas Receptor; C505530:CASP8 protein, human; D053181:Caspase 8; D020169:Caspases